Skip to Content

MYLAN 5340 MYLAN 5340 (Diltiazem CD 240 mg)

Pill imprint MYLAN 5340 MYLAN 5340 has been identified as Diltiazem hydrochloride extended-release (XR) 240 mg.

Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; atrial flutter; supraventricular tachycardia; heart failure (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 240 mg is not a controlled substance under the Controlled Substance Act (CSA).

Diltiazem hydrochloride extended-release (XR) 240 mg MYLAN 5340 MYLAN 5340
Diltiazem hydrochloride extended-release (XR) 240 mg MYLAN 5340 MYLAN 5340 Front
Diltiazem hydrochloride extended-release (XR) 240 mg MYLAN 5340 MYLAN 5340 Back
Diltiazem hydrochloride extended-release (XR) 240 mg MYLAN 5340 MYLAN 5340
Diltiazem hydrochloride extended-release (XR)
Imprint:
MYLAN 5340 MYLAN 5340
Strength:
240 mg
Color:
Blue & Pink
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Group IV antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5340
Inactive Ingredients:
ammonia
silicon dioxide
dibutyl sebacate
ethylcelluloses
hypromelloses
magnesium stearate
maltodextrin
microcrystalline cellulose
oleic acid
polyethylene glycol
sodium lauryl sulfate
FD&C Blue No. 1
FD&C Red No. 40
gelatin
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 2
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0949 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide